LMT-28
LMT-28 is a selective small molecule inhibitor that targets the IL-6 signaling pathway by blocking IL-6-induced phosphorylation of gp130, JAK2, and STAT3. It is a valuable research tool for studying inflammation, cancer, and autoimmune diseases in both cellular and animal models.
Product Specifications
CAS Number
1239600-18-0
Product Name Alternative
ILReceptor, IL-6, IL Receptor, LMT 28, LMT28, LMT-28
Field of Research
Immunology & Inflammation
Purity
97.55% (May vary between batches)
Solubility
DMSO:90 mg/mL (289 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.42 mM)
Smiles
CCCCCC (=C) [C@@H] (O) [C@H] (C) C (=O) N1[C@H] (COC1=O) C (C) C
Molecular Formula
C17H29NO4
Molecular Weight
311.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog